Cargando…

Cognition Deficits in Parkinson's Disease: Mechanisms and Treatment

Parkinson's disease (PD) is the second most common progressive neurodegenerative disorder mainly in middle-elderly population, which represents diverse nonmotor symptoms (NMS) besides such well-documented motor symptoms as bradykinesia, resting tremor, rigidity, and postural instability. With t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Congcong, Lv, Longqin, Mao, Shanping, Dong, Huimin, Liu, Baohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128056/ https://www.ncbi.nlm.nih.gov/pubmed/32269747 http://dx.doi.org/10.1155/2020/2076942

Ejemplares similares

Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
por: Lv, Longqin, et al.
Publicado: (2020)

Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents
por: Decourt, Mélina, et al.
Publicado: (2021)

Prodromal Cognitive Deficits and the Risk of Subsequent Parkinson’s Disease
por: Speelberg, Daniël H. B., et al.
Publicado: (2022)

Modulating brain networks associated with cognitive deficits in Parkinson’s disease
por: Beheshti, Iman, et al.
Publicado: (2021)

Schisandrin B protects PC12 cells by decreasing the expression of amyloid precursor protein and vacuolar protein sorting 35★
por: Yan, Mingmin, et al.
Publicado: (2012)

Genetic deletion of Rnd3 suppresses apoptosis through NF-κB signaling in the brain
por: Dong, Huimin, et al.
Publicado: (2021)

Genetic deletion of Rnd3 in neural stem cells promotes proliferation via upregulation of Notch signaling
por: Dong, Huimin, et al.
Publicado: (2017)

Verification of the Cross Immunoreactivity of A60, a Mouse Monoclonal Antibody against Neuronal Nuclear Protein
por: Mao, Shanping, et al.
Publicado: (2016)

The Interrelation between Reactive Oxygen Species and Autophagy in Neurological Disorders
por: Fang, Congcong, et al.
Publicado: (2017)

A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications
por: Kelly, Valerie E., et al.
Publicado: (2012)

Deficits in Emotion Perception and Cognition in Patients with Parkinson's Disease: A Systematic Review
por: Gothwal, Mohit, et al.
Publicado: (2022)

Electrophysiological Evidence of Auditory and Cognitive Processing Deficits in Parkinson Disease
por: Folmer, Robert L., et al.
Publicado: (2021)

Small GTPase RHOE/RND3, a new critical regulator of NF‐κB signalling in glioblastoma multiforme?
por: Sun, Qian, et al.
Publicado: (2019)

BILINGUAL SPEAKERS POSTPONE SYMPTOMS OF COGNITIVE DEFICIT IN PARKINSON’S DISEASE
por: Saidi, Ladan Ghazi
Publicado: (2019)

Neurobehavioral Mechanisms of Temporal Processing Deficits in Parkinson's Disease
por: Harrington, Deborah L., et al.
Publicado: (2011)

Rat Models of Vocal Deficits in Parkinson’s Disease
por: Krasko, Maryann N., et al.
Publicado: (2021)

Relationships between Freezing of Gait Severity and Cognitive Deficits in Parkinson’s Disease
por: Scholl, Jamie L., et al.
Publicado: (2021)

Association between Olfactory Deficit and Motor and Cognitive Function in Parkinson’s Disease
por: Yoo, Han Soo, et al.
Publicado: (2020)

Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism
por: Cleret de Langavant, Laurent, et al.
Publicado: (2022)

Cognitive Deficits in Parkinson's Disease Are Associated with Neuronal Dysfunction and Not White Matter Lesions
por: Schröter, Nils, et al.
Publicado: (2023)

Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease
por: Perez-Lloret, Santiago, et al.
Publicado: (2016)

Cognitive and Behavior Deficits in Parkinson’s Disease with Alteration of FDG-PET Irrespective of Age
por: Lauretani, Fulvio, et al.
Publicado: (2021)

Association of Cognitive Deficit with Glutamate and Insulin Signaling in a Rat Model of Parkinson’s Disease
por: Knezovic, Ana, et al.
Publicado: (2023)

Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease
por: Price, Catherine C., et al.
Publicado: (2016)

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo‐perceptual deficits
por: Weil, Rimona S., et al.
Publicado: (2018)

Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction
por: Maier, Franziska, et al.
Publicado: (2023)

Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease
por: Nissen, Sara Konstantin, et al.
Publicado: (2020)

Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s Disease
por: Devignes, Quentin, et al.
Publicado: (2021)

GBA Variants and Parkinson Disease: Mechanisms and Treatments
por: Smith, Laura, et al.
Publicado: (2022)

Vascular Cognitive Impairment: Information from Animal Models on the Pathogenic Mechanisms of Cognitive Deficits
por: Hort, Jakub, et al.
Publicado: (2019)

Parkinson's Disease and Cognitive Impairment
por: Yang, Yang, et al.
Publicado: (2016)

Cognitive Deficits in Myopathies
por: Peristeri, Eleni, et al.
Publicado: (2020)

Cognitive and Behavioral Inhibition Deficits in Parkinson’s Disease: The Hayling Test as a Reliable Marker
por: Siquier, Antònia, et al.
Publicado: (2021)

Deficits in Emotion Recognition and Theory of Mind in Parkinson’s Disease Patients With and Without Cognitive Impairments
por: Dodich, Alessandra, et al.
Publicado: (2022)

Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment
por: Yang, Jihyun, et al.
Publicado: (2022)

Cognitive Deficit and Aberrant Intrinsic Brain Functional Network in Early-Stage Drug-Naive Parkinson’s Disease
por: Zhang, Lan, et al.
Publicado: (2022)

Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
por: Martínez, Antón L., et al.
Publicado: (2021)

Parkinson’s Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson’s Disease: A Systematic Review
por: Rosca, Elena Cecilia, et al.
Publicado: (2020)

Motor Speed Matters! Cognitive Profile of Parkinson’s Disease Patients With and Without Deficits in Motor Speed
por: Menon, Vidya, et al.
Publicado: (2021)

Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease
por: Gargouri, Fatma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4ooqf1q7e1othmapbekiruidrv